Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.

Wells JW, Evans CH, Scott MC, Rütgen BC, O'Brien TD, Modiano JF, Cvetkovic G, Tepic S.

PLoS One. 2013;8(1):e54464. doi: 10.1371/journal.pone.0054464. Epub 2013 Jan 24.

2.

Biological activity of dihydroartemisinin in canine osteosarcoma cell lines.

Hosoya K, Murahari S, Laio A, London CA, Couto CG, Kisseberth WC.

Am J Vet Res. 2008 Apr;69(4):519-26. doi: 10.2460/ajvr.69.4.519.

PMID:
18380584
3.

Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.

Robson H, Meyer S, Shalet SM, Anderson E, Roberts S, Eden OB.

Med Pediatr Oncol. 2002 Dec;39(6):573-80.

PMID:
12376980
4.

Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.

McMahon MB, Bear MD, Kulp SK, Pennell ML, London CA.

Am J Vet Res. 2010 Jul;71(7):799-808. doi: 10.2460/ajvr.71.7.799.

PMID:
20594083
5.

Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells.

Fahey CE, Milner RJ, Kow K, Bacon NJ, Salute ME.

Anticancer Drugs. 2013 Jun;24(5):519-26. doi: 10.1097/CAD.0b013e32836002ba.

PMID:
23466652
6.

Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.

Roepke M, Diestel A, Bajbouj K, Walluscheck D, Schonfeld P, Roessner A, Schneider-Stock R, Gali-Muhtasib H.

Cancer Biol Ther. 2007 Feb;6(2):160-9. Epub 2007 Feb 5.

PMID:
17218778
7.

Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.

Lam TL, Wong GK, Chong HC, Cheng PN, Choi SC, Chow TL, Kwok SY, Poon RT, Wheatley DN, Lo WH, Leung YC.

Cancer Lett. 2009 May 8;277(1):91-100. doi: 10.1016/j.canlet.2008.11.031. Epub 2009 Jan 12.

PMID:
19138817
8.

Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs.

Royals SR, Farese JP, Milner RJ, Lee-Ambrose L, van Gilder J.

Am J Vet Res. 2005 Nov;66(11):1961-7.

PMID:
16334957
9.

Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.

Liu X, Choy E, Harmon D, Yang S, Yang C, Mankin H, Hornicek FJ, Duan Z.

Anticancer Drugs. 2011 Jun;22(5):444-53. doi: 10.1097/CAD.0b013e32834513f4.

PMID:
21399492
10.

Antimetastatic activity of honokiol in osteosarcoma.

Steinmann P, Walters DK, Arlt MJ, Banke IJ, Ziegler U, Langsam B, Arbiser J, Muff R, Born W, Fuchs B.

Cancer. 2012 Apr 15;118(8):2117-27. doi: 10.1002/cncr.26434. Epub 2011 Sep 20.

11.
12.

The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.

Wolfesberger B, Tonar Z, Gerner W, Skalicky M, Heiduschka G, Egerbacher M, Thalhammer JG, Walter I.

Res Vet Sci. 2010 Feb;88(1):94-100. doi: 10.1016/j.rvsc.2009.06.009. Epub 2009 Aug 7.

PMID:
19665156
13.

Pegylated arginase I: a potential therapeutic approach in T-ALL.

Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, Cole J, Rodriguez PC.

Blood. 2010 Jun 24;115(25):5214-21. doi: 10.1182/blood-2009-12-258822. Epub 2010 Apr 20.

14.

Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.

Agrawal V, Woo JH, Mauldin JP, Jo C, Stone EM, Georgiou G, Frankel AE.

Anticancer Drugs. 2012 Jan;23(1):51-64. doi: 10.1097/CAD.0b013e32834ae42b.

PMID:
21955999
15.

Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells.

Murata M, Towatari M, Kosugi H, Tanimoto M, Ueda R, Saito H, Naoe T.

Jpn J Cancer Res. 2000 Nov;91(11):1154-60.

PMID:
11092981
16.

Effects of lycopene on proliferation and death of canine osteosarcoma cells.

Wakshlag JJ, Balkman CE.

Am J Vet Res. 2010 Nov;71(11):1362-70. doi: 10.2460/ajvr.71.11.1362.

PMID:
21034328
17.

Alpha-tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis.

Alleva R, Benassi MS, Pazzaglia L, Tomasetti M, Gellert N, Borghi B, Neuzil J, Picci P.

Cancer Lett. 2006 Feb 8;232(2):226-35.

PMID:
16458119
19.

Anticancer effects of zoledronic acid against human osteosarcoma cells.

Kubista B, Trieb K, Sevelda F, Toma C, Arrich F, Heffeter P, Elbling L, Sutterlüty H, Scotlandi K, Kotz R, Micksche M, Berger W.

J Orthop Res. 2006 Jun;24(6):1145-52.

20.

Supplemental Content

Support Center